Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - OncoCyte Corp | ex32.htm |
| EX-31 - EXHIBIT 31 - OncoCyte Corp | ex31.htm |
| EX-10.29 - EXHIBIT 10.29 - OncoCyte Corp | ex10_29.htm |
| EX-10.26 - EXHIBIT 10.26 - OncoCyte Corp | ex10_26.htm |
| EX-4.5 - EXHIBIT 4.5 - OncoCyte Corp | ex4_5.htm |
| EX-4.4 - EXHIBIT 4.4 - OncoCyte Corp | ex4_4.htm |
| EX-4.3 - EXHIBIT 4.3 - OncoCyte Corp | ex4_3.htm |
| 10-K - ONCOCYTE CORPORATION 10-K 12-31-2016 - OncoCyte Corp | form10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Amendment No. 2 to Registration Statement on Form S-1 (No. 333-213810) and in Registration Statement on Form S-8 (No. 333-208935) of OncoCyte Corporation of our report dated February 27, 2017 relating to the financial statements of OncoCyte Corporation, which appears in this Annual Report on Form 10-K.
/s/ OUM & Co. LLP
San Francisco, California
February 27, 2017